New Cancer Research Strategic Framework for Northern Ireland
Date published:
Health Minister Mike Nesbitt has published Northern Ireland's first ever Cancer Research Strategic Framework designed to strengthen cancer research, innovation and collaboration across Northern Ireland.
Health Minister Mike Nesbitt has published Northern Ireland's new Cancer Research Strategic Framework designed to strengthen cancer research, innovation and collaboration across Northern Ireland.
The Framework sets out a clear direction for enhancing research excellence, removing barriers, increasing participation in clinical trials, and improving outcomes for cancer patients. It builds on the ambitions of the NI Cancer Strategy and aligns with the Health and Care Reset Plan commitment to develop a world-leading health and care research and innovation ecosystem.
A new Cancer Research Advisory Group will oversee delivery of the Framework. The Group will be co-chaired by Professor Ian Young, Chief Scientific Adviser at the Department of Health, and Professor Mark Lawler, Professor of Digital Health and Chair in Translational Cancer Genomics at Queen's University Belfast, with Cancer Research UK as a key member.
Health Minister Mike Nesbitt said:
"This Framework demonstrates a clear commitment to strengthening cancer research in Northern Ireland. By uniting expertise across health and social care, academia, industry and the voluntary sector, we can accelerate progress and deliver real improvements in prevention, diagnosis and treatment.
"Our researchers and clinicians already make an outstanding contribution to cancer care. This Framework ensures they are supported to continue that work, driving innovation that will translate directly into better outcomes for patients. I am very grateful to everyone who has contributed to its development."
Professor Ian Young said:
"The Cancer Research Advisory Group will play a pivotal role in ensuring that the Framework delivers on its ambitions. By building capacity, fostering collaboration and strengthening infrastructure, we can create the conditions needed for high-quality research that benefits patients."
Professor Mark Lawler said:
"I praise the Minister for this initiative - it's the first time we've had a Cancer Research Strategic Framework. Make no mistake, this is a pivotal moment for cancer research in Northern Ireland. Cancer research is no longer a "nice to have". It's a "must have" in order to deliver 21st century care for our patients. By connecting our scientific, clinical, innovation and patient communities, we can enhance our research efforts, attract investment, and ensure discoveries are rapidly translated into better care and outcomes. I am honoured to serve as Co-Chair to what I believe is a new dawn for cancer research in Northern Ireland."
The launch of the Framework and Advisory Group reinforces Northern Ireland's growing reputation for excellence in health research and innovation. It underlines the Department's determination to ensure that world-class science and collaboration continue to improve the lives of people affected by cancer.
